Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| RNA polymerase | R-HSA-73864 | map03020 | ergocalciferol | 5280793 | drug-path |
| Glioma | Q9NZM4 | map05214 | cisapride | 6917698 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | cisapride | 6917698 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | cisapride | 6917698 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | cisapride | 6917698 | drug-path |
| Base excision repair | R-HSA-73884 | map03410 | cisapride | 6917698 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | cisapride | 6917698 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | cisapride | 6917698 | drug-path |
| Basal transcription factors | R-HSA-3232118 | map03022 | cisapride | 6917698 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | puromycin | 4633 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | puromycin | 4633 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | puromycin | 4633 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | puromycin | 4633 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | puromycin | 4633 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | puromycin | 4633 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | puromycin | 4633 | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | puromycin | 4633 | drug-path |
| Shigellosis | 0 | map05131 | puromycin | 4633 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | puromycin | 4633 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | puromycin | 4633 | drug-path |